AAAAAA

   
Results: 1-4 |
Results: 4
Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS
Authors: Waubant, E Gee, L Bacchetti, P Sloan, R Cotleur, A Rudick, R Goodkin, D
Citation: E. Waubant et al., Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS, J NEUROIMM, 112(1-2), 2001, pp. 139-145
Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients
Authors: Bjartmar, C Kidd, G Mork, S Rudick, R Trapp, BD
Citation: C. Bjartmar et al., Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients, ANN NEUROL, 48(6), 2000, pp. 893-901
Extended observations on MS patients treated with IM interferon-beta 1a (Avonex (TM)): implications for modern MS trials and therapeutics - Presentedin part at Pathogenic and Regulatory Cells in Demyelinating Diseases, Rome, Italy, September 12-15, 1999.
Authors: Jacobs, L Rudick, R Simon, J
Citation: L. Jacobs et al., Extended observations on MS patients treated with IM interferon-beta 1a (Avonex (TM)): implications for modern MS trials and therapeutics - Presentedin part at Pathogenic and Regulatory Cells in Demyelinating Diseases, Rome, Italy, September 12-15, 1999., J NEUROIMM, 107(2), 2000, pp. 167-173
Axonal pathology in multiple sclerosis: relationship to neurologic disability
Authors: Trapp, BD Ransohoff, R Rudick, R
Citation: Bd. Trapp et al., Axonal pathology in multiple sclerosis: relationship to neurologic disability, CURR OP NEU, 12(3), 1999, pp. 295-302
Risultati: 1-4 |